lignan
wide
produc
variou
plant
speci
class
natur
product
share
structur
similar
usual
contain
core
scaffold
form
two
phenylpropanoid
unit
lignan
possess
divers
pharmacolog
properti
includ
antivir
activ
report
recent
year
review
discuss
distribut
lignan
natur
accord
structur
classif
provid
comprehens
summari
antivir
activ
among
two
type
antivir
lignanspodophyllotoxin
bicyclol
use
treat
vener
wart
chronic
hepat
b
chb
clinic
serv
exampl
use
lignan
antiviralsar
discuss
detail
prospect
lignan
antivir
drug
discoveri
also
discuss
lignan
larg
group
natur
occur
compound
deriv
shikim
acid
biosynthet
pathway
structur
lignan
contain
basic
scaffold
two
phenylpropanoid
unit
monom
form
lignan
cinnam
acid
cinnamyl
alcohol
propenyl
benzen
allyl
benzen
molecular
linkag
monom
occur
posit
also
refer
compound
design
classic
lignan
contrast
compound
group
neolignan
main
structur
unit
coupl
way
non
linkag
figur
show
monom
classif
neolignan
vari
structur
classic
lignan
lignan
wide
distribut
plant
kingdom
exist
plant
root
rhizom
stem
leav
flower
fruit
seed
xylem
resin
plant
lauracea
famili
especi
genera
machilu
ocotea
nectandra
rich
sourc
lignan
addit
annonacea
orchidacea
berberidacea
schisandracea
famili
contain
larg
number
constitu
lignan
neolignan
date
lignan
found
famili
plant
kingdom
classic
lignan
neolignan
character
usual
present
dimer
trimer
tetram
lignan
plant
free
state
combin
glycon
form
glycosid
deriv
structur
divers
lignan
discov
surpris
mani
attract
pharmacolog
activ
lignan
famili
antitumor
antioxid
antibacteri
immunosuppress
antiasthmat
properti
report
pertin
review
mani
lignan
identifi
antivir
activ
tubulin
bind
revers
transcriptas
inhibit
integras
inhibit
topoisomeras
inhibit
includ
report
mechan
antivir
activ
highlight
antivir
activ
mechan
action
moa
differ
lignan
deriv
lignan
display
vast
structur
divers
due
numer
potenti
coupl
mode
phenoxi
radic
mention
group
two
subclass
classic
lignan
neolignan
next
discuss
antivir
lignan
possibl
moa
accord
differ
subclass
summar
tabl
end
section
classic
lignan
contain
dimer
structur
form
two
phenyl
propan
unit
differ
degre
oxid
sidechain
differ
substitut
pattern
aromat
moieti
classifi
six
major
subtypesdibenzylbutan
dibenzylbutyrolacton
arylnaphthalenesaryltetralin
substitut
tetrahydrofuran
dibenzocyclooctadien
figur
illustr
structur
relationship
among
structur
divers
lignan
discov
surpris
mani
attract
pharmacolog
activ
lignan
famili
antitumor
antioxid
antibacteri
immunosuppress
antiasthmat
properti
report
pertin
review
mani
lignan
identifi
antivir
activ
tubulin
bind
revers
transcriptas
inhibit
integras
inhibit
topoisomeras
inhibit
includ
report
mechan
antivir
activ
highlight
antivir
activ
mechan
action
moa
differ
lignan
deriv
lignan
display
vast
structur
divers
due
numer
potenti
coupl
mode
phenoxi
radic
mention
group
two
subclass
classic
lignan
neolignan
next
discuss
antivir
lignan
possibl
moa
accord
differ
subclass
summar
tabl
end
section
classic
lignan
contain
dimer
structur
form
linkag
two
phenyl
propan
unit
differ
degre
oxid
sidechain
differ
substitut
pattern
aromat
moieti
classifi
six
major
subtypesdibenzylbutan
dibenzylbutyrolacton
arylnaphthalenesaryltetralin
substitut
tetrahydrofuran
dibenzocyclooctadien
figur
illustr
structur
relationship
among
relationship
differ
classic
lignan
depict
basic
mother
nucleu
structur
differ
subtyp
classic
lignan
main
structur
featur
subclass
linkag
dibenzylbutan
central
posit
basic
structur
classic
lignan
subtyp
lignan
deriv
structur
differ
chemic
reaction
dibenzylbutan
also
known
simpl
lignan
simplest
classic
lignan
lignan
subtyp
without
cycliz
phenylpropan
dimer
linkag
dibenzylbutan
lignan
also
show
increas
divers
due
multipl
possibl
oxid
state
along
butan
chain
niranthin
nordihydroguaiaret
acid
ndga
terameprocol
tmp
repres
compound
antivir
activ
subclass
figur
show
structur
niranthin
compound
first
isol
phyllanthu
niruri
linn
famili
euphorbiacea
long
use
folk
medicin
liver
protect
antihepat
b
viru
hbv
mani
asian
countri
rayl
screen
compound
phyllanthu
speci
vitro
niranthin
show
best
antihbsag
activ
among
evalu
antihbv
activ
vitro
niranthin
found
significantli
decreas
secret
hbsag
hbeag
valu
human
hbvtransfect
cell
line
respect
vivo
niranthin
treatment
dhbvinfect
duckl
significantli
reduc
serum
dhbv
dna
hbsag
hbeag
alt
ast
mechanist
studi
show
niranthin
inhibit
dhbv
dna
replic
also
hbv
antigen
express
suggest
niranthin
act
antihbv
agent
least
two
target
ndga
isol
leav
larrea
tridentata
zygophyllacea
plant
known
creosot
bush
tradit
use
folk
medicin
across
differ
countri
region
differ
diseas
report
ndga
exert
benefici
effect
divers
diseas
like
cancer
renal
damag
alzheim
diseas
neurodegen
patholog
molecular
level
ndga
potent
scaveng
reactiv
oxygen
speci
ndga
identifi
inhibit
replic
relat
dengu
viru
denv
moa
show
inhibit
denv
infect
target
genom
replic
viral
assembl
moreov
ndga
show
effect
hepat
c
viru
hcv
west
nile
viru
wnv
zika
viru
zikv
vitro
influenza
virus
iav
ndga
suppress
replic
iav
induct
cytokin
trypsin
improv
anim
surviv
see
tabl
detail
dibenzylbutan
also
known
simpl
lignan
simplest
classic
lignan
lignan
subtyp
without
cycliz
phenylpropan
dimer
linkag
dibenzylbutan
lignan
also
show
increas
divers
due
multipl
possibl
oxid
state
along
butan
chain
niranthin
nordihydroguaiaret
acid
ndga
terameprocol
tmp
repres
compound
antivir
activ
subclass
figur
show
structur
tmp
shorter
titl
tetraomethyl
nordihydroguaiaret
acid
methyl
deriv
ndga
also
initi
found
resin
creosot
bush
deriv
ndga
test
antivir
effect
wnv
zikv
simultan
ndga
result
show
compound
inhibit
infect
wnv
zika
good
similar
valu
moa
like
impair
viral
replic
meanwhil
pollara
show
tmp
inhibit
poxviru
growth
vitro
prevent
effici
spread
viru
particl
cell
cell
addit
report
regard
antivir
activ
tmp
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
moreov
made
vagin
ointment
women
hpvlink
cervic
intraepitheli
neoplasia
show
excel
safeti
profil
phase
iii
trial
besid
xu
isol
four
new
lignan
aerial
part
justicia
procumben
acanthacea
test
activ
one
new
secoisolariciresinol
dimethyleth
acet
exhibit
activ
vitro
dibenzylbutyrolacton
also
known
lignanolid
base
dibenzylbutan
carbonyl
lignanolid
often
found
plant
theirmonodehydrogen
didehydrogen
compound
correspond
deriv
repres
compound
antivir
activ
subclass
arctigenin
atg
yatein
hinokinin
figur
atg
initi
isol
arctium
lappa
l
composita
far
research
antivir
activ
mainli
focus
iav
hiv
erythrocyt
agglutin
test
show
atg
inhibit
replic
iav
vitro
inhibit
shown
concentr
mm
base
hemagglutin
titer
vivo
atg
reduc
lung
index
increas
surviv
rate
infect
mice
induc
interferon
level
normal
mice
suggest
mechanist
atg
induc
product
interferon
atg
glycosid
arctiin
also
shown
oral
effect
less
oseltamivir
result
suggest
good
choic
combin
arctiin
oseltamivir
iav
immunocompromis
mice
infect
iav
addit
atg
strongli
inhibit
niranthin
compound
first
isol
phyllanthu
niruri
linn
famili
euphorbiacea
long
use
folk
medicin
liver
protect
antihepat
b
viru
hbv
mani
asian
countri
rayl
screen
compound
phyllanthu
speci
vitro
niranthin
show
best
antihbsag
activ
among
evalu
antihbv
activ
vitro
niranthin
found
significantli
decreas
secret
hbsag
hbeag
ic
valu
human
hbvtransfect
cell
line
respect
vivo
niranthin
treatment
dhbvinfect
duckl
significantli
reduc
serum
dhbv
dna
hbsag
hbeag
alt
ast
mechanist
studi
show
niranthin
inhibit
dhbv
dna
replic
also
hbv
antigen
express
suggest
niranthin
act
antihbv
agent
least
two
target
ndga
isol
leav
larrea
tridentata
zygophyllacea
plant
known
creosot
bush
tradit
use
folk
medicin
across
differ
countri
region
differ
diseas
report
ndga
exert
benefici
effect
divers
diseas
like
cancer
renal
damag
alzheim
diseas
neurodegen
patholog
molecular
level
ndga
potent
scaveng
reactiv
oxygen
speci
ndga
identifi
inhibit
replic
relat
dengu
viru
denv
moa
show
inhibit
denv
infect
target
genom
replic
viral
assembl
moreov
ndga
show
effect
hepat
c
viru
hcv
west
nile
viru
wnv
zika
viru
zikv
vitro
influenza
virus
iav
ndga
suppress
replic
iav
induct
cytokin
trypsin
improv
anim
surviv
see
tabl
detail
tmp
shorter
titl
tetraomethyl
nordihydroguaiaret
acid
methyl
deriv
ndga
also
initi
found
resin
creosot
bush
deriv
ndga
test
antivir
effect
wnv
zikv
simultan
ndga
result
show
compound
inhibit
infect
wnv
zika
good
similar
ic
valu
moa
like
impair
viral
replic
meanwhil
pollara
show
tmp
inhibit
poxviru
growth
vitro
prevent
effici
spread
viru
particl
cell
cell
addit
report
regard
antivir
activ
tmp
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
moreov
made
vagin
ointment
women
hpvlink
cervic
intraepitheli
neoplasia
show
excel
safeti
profil
phase
iii
trial
besid
xu
isol
four
new
lignan
aerial
part
justicia
procumben
acanthacea
test
activ
one
new
secoisolariciresinol
dimethyleth
acet
exhibit
activ
ic
vitro
dibenzylbutyrolacton
also
known
lacton
lignanolid
base
dibenzylbutan
epoxi
carbonyl
lignanolid
often
found
plant
theirmonodehydrogen
didehydrogen
compound
correspond
deriv
repres
compound
antivir
activ
subclass
arctigenin
atg
yatein
hinokinin
figur
cov
human
cytomegaloviru
hcmv
defect
data
vitro
indepth
research
moa
relationship
arylnaphthalen
aryltetralin
subclass
interest
due
decept
structur
similar
compound
base
dibenzylbutan
form
cycliz
six
site
one
unit
seven
site
anoth
unit
subtl
structur
differ
lie
whether
b
ring
consist
benzen
ring
sixmemb
ring
arylnaphthalen
also
name
benzen
tetrahydronaphthalen
mean
bring
structur
consist
sixmemb
ring
aryltetralin
name
benzen
naphthalen
bring
structur
consist
benzen
repres
compound
arylnaphthalen
diphyllin
dgp
podophyllotoxin
repres
aryltetralin
figur
diphyllin
natur
compon
plant
naphthalen
one
hydroxyl
lignan
exist
haplophyllum
albertiregelii
h
bucharicum
h
perforatum
rutacea
show
broad
atg
initi
isol
arctium
lappa
l
composita
far
research
antivir
activ
mainli
focus
iav
hiv
erythrocyt
agglutin
test
show
atg
inhibit
replic
iav
vitro
inhibit
shown
concentr
mm
base
hemagglutin
titer
vivo
atg
reduc
lung
index
increas
surviv
rate
infect
mice
induc
interferon
level
normal
mice
suggest
mechanist
atg
induc
product
interferon
atg
glycosid
arctiin
also
shown
oral
effect
less
oseltamivir
result
suggest
good
choic
combin
arctiin
oseltamivir
iav
immunocompromis
mice
infect
iav
addit
atg
strongli
inhibit
express
protein
vitro
moa
show
target
revers
transcript
studi
structureact
relationship
sar
show
structur
lacton
necessari
number
arrang
phenol
hydroxyl
group
import
activ
lignanolid
yatein
isol
chamaecypari
obtus
cupressacea
could
significantli
suppress
replic
hela
cell
without
appar
cytotox
moa
show
yatein
inhibit
alpha
gene
express
includ
express
gene
arrest
dna
synthesi
structur
protein
express
hela
cell
hinokinin
first
isol
ether
extract
chamecypari
obtusa
also
found
differ
speci
phyllanthu
euphobiacea
aristolochia
aristolochiacea
piper
piperacea
virola
myristicacea
linum
linacea
antiinflammatori
antimicrobi
activ
cytotox
compound
extens
studi
meanwhil
show
good
antivir
activ
human
hbv
hiv
sarsviru
sarscov
human
cytomegaloviru
hcmv
defect
data
vitro
indepth
research
moa
relationship
arylnaphthalen
aryltetralin
subclass
interest
due
decept
structur
similar
compound
base
dibenzylbutan
form
cycliz
six
site
one
unit
seven
site
anoth
unit
subtl
structur
differ
lie
whether
b
ring
consist
benzen
ring
sixmemb
ring
arylnaphthalen
also
name
benzen
tetrahydronaphthalen
mean
bring
structur
consist
sixmemb
ring
aryltetralin
name
benzen
naphthalen
bring
structur
consist
benzen
repres
compound
arylnaphthalen
diphyllin
dgp
podophyllotoxin
repres
aryltetralin
figur
substitut
tetrahydrofuran
also
design
monoepoxylignan
refer
format
furan
tetrahydrofuran
structur
base
dibenzylbutan
repres
compound
lariciresinol
la
deriv
figur
show
structur
detail
lot
tradit
medicin
plant
patrinia
scabra
bung
caprifoliacea
stelleropsi
tianschanica
rutacea
rubia
philippinensi
rubiacea
ingredi
la
deriv
among
plant
isati
indigotica
fort
crucifera
studi
root
root
isati
indigotica
fort
famou
antivir
tradit
medicin
china
diphyllin
natur
compon
plant
naphthalen
one
hydroxyl
lignan
exist
haplophyllum
albertiregelii
h
bucharicum
h
perforatum
rutacea
show
broadspectrum
antivir
activ
potent
vacuolar
atpas
vatpas
inhibitor
exampl
block
zikv
infect
cell
ic
also
alter
cellular
suscept
iav
inhibit
endosom
acidif
thu
interf
downstream
viru
replic
report
regard
antivir
effect
glycosyl
diphyllin
dgp
also
known
patentiflorin
first
isol
plant
justicia
gendarussa
acanthacea
glycosyl
diphyllin
exhibit
antizikv
activ
vitro
vivo
display
broadspectrum
antivir
activ
flavivirus
moa
show
dgp
inhibit
zikv
fusion
cellular
membran
infect
prevent
acidif
endosomallysosom
compart
target
cell
besid
also
display
potent
activ
broad
spectrum
hiv
strain
ic
valu
rang
nm
moa
show
act
potenti
inhibitor
revers
transcript
podophyllotoxin
one
bestcharacter
lignan
type
aryletralin
lignan
lacton
initi
found
dysosma
verspielli
rhixoma
et
radix
american
mandrak
mayappl
belong
famili
berberidacea
one
research
interest
podophyllotoxin
focus
anticanc
activ
furthermor
first
cite
topic
treatment
vener
wart
condyloma
acuminatum
ailment
caus
papillomaviru
clinic
random
control
trial
data
case
show
podophyllotoxin
solut
benefici
effect
anoenit
wart
effect
safe
untreat
anogenit
wart
immunocompet
individu
substitut
tetrahydrofuran
also
design
monoepoxylignan
refer
format
furan
tetrahydrofuran
structur
base
dibenzylbutan
repres
compound
lariciresinol
la
deriv
figur
show
structur
detail
lot
tradit
medicin
plant
patrinia
scabra
bung
caprifoliacea
stelleropsi
tianschanica
rutacea
rubia
philippinensi
rubiacea
ingredi
la
deriv
among
plant
isati
indigotica
fort
crucifera
studi
root
substitut
tetrahydrofuran
also
design
monoepoxylignan
refer
format
furan
tetrahydrofuran
structur
base
dibenzylbutan
repres
compound
lariciresinol
la
deriv
figur
show
structur
detail
lot
tradit
medicin
plant
patrinia
scabra
bung
caprifoliacea
stelleropsi
tianschanica
rutacea
rubia
philippinensi
rubiacea
ingredi
la
deriv
among
plant
isati
indigotica
fort
crucifera
studi
root
root
isati
indigotica
fort
famou
antivir
tradit
medicin
china
call
radix
isatidi
banlangen
chines
preval
sar
tradit
chines
medicin
product
contain
radix
isatidi
stock
china
far
lot
deriv
la
structur
isol
radix
isatidi
antivir
activ
demonstr
exampl
shown
inhibit
iavinduc
proinflammatori
respons
underli
defens
mechan
iav
infect
pharmacolog
action
immun
system
signal
transduct
cell
cycl
metabol
alphamethyl
butano
show
low
amount
activ
isatindolignanosid
shown
antivir
activ
coxsackieviru
si
valu
respect
clemastanin
b
activ
ingredi
radix
isatidi
show
inhibit
differ
subtyp
human
iav
influenza
b
root
isati
indigotica
fort
famou
antivir
tradit
medicin
china
call
radix
isatidi
banlangen
chines
preval
sar
tradit
chines
medicin
product
contain
radix
isatidi
stock
china
far
lot
deriv
la
structur
isol
radix
isatidi
antivir
activ
demonstr
exampl
shown
inhibit
iavinduc
proinflammatori
respons
underli
defens
mechan
iav
infect
pharmacolog
action
immun
system
signal
transduct
cell
cycl
metabol
lariciresinol
alphamethyl
butano
show
low
amount
activ
isatindolignanosid
shown
antivir
activ
coxsackieviru
ic
also
known
bisepoxylignan
lignan
doubl
tetrahydrofuran
ring
structur
form
two
side
chain
phenylpropanoid
interlink
form
two
epoxi
structur
report
compound
antivir
activ
figur
also
known
bisepoxylignan
lignan
doubl
tetrahydrofuran
ring
structur
form
two
side
chain
phenylpropanoid
interlink
form
two
epoxi
structur
report
compound
antivir
activ
figur
phillygenin
major
activ
constitu
fructu
forsythia
oleacea
suppress
high
glucoseinduc
lipid
accumul
antibacteri
antioxid
activ
could
also
potenti
therapeut
agent
allevi
inflamm
antivir
studi
show
phillygenin
good
protect
effect
infect
caus
iav
could
reduc
inflamm
caus
iav
vivo
meanwhil
sesamin
isol
seed
sesamum
indicum
pedaliacea
antiinflammatori
cytokin
human
pbmc
induc
howev
report
demonstr
direct
antiinfluenza
activ
structur
subclass
lignan
biphenyl
structur
also
eightmemb
ring
structur
synthes
biphenyl
side
chainr
figur
show
structur
dibenzocyclooctadien
correspond
compound
far
lignan
isol
identifi
speci
schisandracea
famili
reason
dibenzocycloocten
lignan
call
schisandra
chinensi
lignan
even
profession
scientif
literatur
schisandra
chinensi
turcz
baill
famou
plant
schisandracea
famili
fruit
call
fructu
schizandra
wide
use
tradit
chines
medicin
treat
hepat
myocardi
disord
hyperlipidemia
neurodegen
diseas
countri
east
asia
other
plant
nine
major
bioactiv
lignan
identifi
dibenzocycloocten
schisandrol
schisandrol
b
angeloylgomisin
h
gomisin
g
schisantherin
schisanhenol
schisandrin
schisandrin
b
schisandrin
c
term
antivir
activ
found
schisandrin
inhibit
denv
replic
via
upregul
antivir
interferon
respons
stat
signal
pathway
schisandrin
schisandrin
b
exhibit
antivir
activ
hiv
schizandrin
c
shown
phillygenin
major
activ
constitu
fructu
forsythia
oleacea
suppress
high
glucoseinduc
lipid
accumul
antibacteri
antioxid
activ
could
also
potenti
therapeut
agent
allevi
inflamm
antivir
studi
show
phillygenin
good
protect
effect
infect
caus
iav
could
reduc
inflamm
caus
iav
vivo
meanwhil
sesamin
isol
seed
sesamum
indicum
pedaliacea
antiinflammatori
cytokin
human
pbmc
induc
howev
report
demonstr
direct
antiinfluenza
activ
structur
subclass
lignan
biphenyl
structur
also
eightmemb
ring
structur
synthes
biphenyl
side
chainr
figur
show
structur
dibenzocyclooctadien
correspond
compound
far
lignan
isol
identifi
speci
schisandracea
famili
reason
dibenzocycloocten
lignan
call
schisandra
chinensi
lignan
even
profession
scientif
literatur
also
known
bisepoxylignan
lignan
doubl
tetrahydrofuran
ring
structur
form
two
side
chain
phenylpropanoid
interlink
form
two
epoxi
structur
report
compound
antivir
activ
figur
phillygenin
major
activ
constitu
fructu
forsythia
oleacea
suppress
high
glucoseinduc
lipid
accumul
antibacteri
antioxid
activ
could
also
potenti
therapeut
agent
allevi
inflamm
antivir
studi
show
phillygenin
good
protect
effect
infect
caus
iav
could
reduc
inflamm
caus
iav
vivo
meanwhil
sesamin
isol
seed
sesamum
indicum
pedaliacea
antiinflammatori
cytokin
human
pbmc
induc
howev
report
demonstr
direct
antiinfluenza
activ
structur
subclass
lignan
biphenyl
structur
also
eightmemb
ring
structur
synthes
biphenyl
side
chainr
figur
show
structur
dibenzocyclooctadien
correspond
compound
far
lignan
isol
identifi
speci
schisandracea
famili
reason
dibenzocycloocten
lignan
call
schisandra
chinensi
lignan
even
profession
scientif
literatur
schisandra
chinensi
turcz
baill
famou
plant
schisandracea
famili
fruit
call
fructu
schizandra
wide
use
tradit
chines
medicin
treat
hepat
myocardi
disord
hyperlipidemia
neurodegen
diseas
countri
east
asia
other
plant
nine
major
bioactiv
lignan
identifi
dibenzocycloocten
schisandrol
schisandrol
b
angeloylgomisin
h
gomisin
g
schisantherin
schisanhenol
schisandrin
schisandrin
b
schisandrin
c
term
antivir
activ
found
schisandrin
inhibit
denv
replic
via
upregul
antivir
interferon
respons
stat
signal
pathway
schisandrin
schisandrin
b
exhibit
antivir
activ
hiv
schizandrin
c
shown
activ
compound
protect
liver
injuri
mice
deriv
schizandrin
c
bicyclol
approv
hepatoprotect
chines
food
drug
administr
cfda
treatment
liver
injuri
bicyclol
bi
methylenedioxi
methoxycarbonyl
biphenyl
analog
activ
compon
schizandrin
c
fructu
schiznadra
illustr
figur
bicyclol
shown
activ
vitro
vivo
clinic
data
show
could
inhibit
viru
replic
patient
infect
hbv
differ
respons
bicyclol
therapi
hbv
genotyp
b
c
statist
signific
result
show
bicyclol
significantli
inhibit
hcv
replic
vitro
hepat
c
patient
mechanist
studi
suggest
antihepat
activ
bicyclol
modul
cytotox
lymphocyt
upregul
host
restrict
factor
gltp
hcv
replic
caus
spontan
restrict
hcv
replic
bicyclol
use
treat
patient
chronic
hepat
b
china
bicyclol
approv
hepatoprotect
chines
food
drug
administr
cfda
treatment
liver
injuri
bicyclol
methylenedioxi
biphenyl
analog
activ
compon
schizandrin
c
fructu
schiznadra
illustr
figur
bicyclol
shown
activ
vitro
vivo
clinic
data
show
could
inhibit
viru
replic
patient
infect
hbv
differ
respons
bicyclol
therapi
hbv
genotyp
b
c
statist
signific
result
show
bicyclol
significantli
inhibit
hcv
replic
vitro
hepat
c
patient
mechanist
studi
suggest
antihepat
activ
bicyclol
modul
cytotox
lymphocyt
upregul
host
restrict
factor
gltp
hcv
replic
caus
spontan
restrict
hcv
replic
bicyclol
use
treat
patient
chronic
hepat
b
china
figur
bicyclol
antihbv
drug
schizandrin
c
isol
f
schizandra
verifi
activ
compound
protect
liver
injuri
mice
ddb
dimethyl
dicarboxyl
biphenyl
analog
schizandrin
c
wide
use
improv
abnorm
liver
function
chb
hepat
china
bicyclol
novel
substitut
ddb
found
effect
protect
liver
injuri
also
show
inhibit
hepat
viru
replic
vitro
vivo
rubrifloralignan
isol
anoth
speci
schisandracea
familyschisandra
rubriflora
inhibit
format
syncytium
induc
cell
death
induc
also
inhibit
replic
hiv
mechanist
rubrifloralignan
shown
inhibit
earli
stage
replic
deriv
gomisin
exhibit
potent
antihiv
activ
si
valu
respect
halogen
gomisin
j
deriv
shown
nonnucleosid
inhibitor
hiv
type
revers
transcriptas
neolignan
class
lignan
contain
also
refer
phenylpropan
linkag
characterist
classic
lignan
group
differ
subtyp
base
natur
posit
linkag
phenylpropan
unit
contrast
classic
lignan
report
antivir
activ
neolignan
figur
show
structur
neolignan
compound
lignan
subtyp
neolignan
receiv
signific
attent
year
due
good
biolog
activ
one
repres
silymarin
flavonolignan
isol
seed
silybum
marianum
commonli
consum
herbal
product
among
hcvinfect
patient
western
countri
besid
show
possess
antioxid
antiinflammatori
hepatoprotect
activ
recent
figur
bicyclol
antihbv
drug
schizandrin
c
isol
f
schizandra
verifi
activ
compound
protect
liver
injuri
mice
ddb
dimethyl
dicarboxyl
biphenyl
analog
schizandrin
c
wide
use
improv
abnorm
liver
function
chb
hepat
china
bicyclol
novel
substitut
ddb
found
effect
protect
liver
injuri
also
show
inhibit
hepat
viru
replic
vitro
vivo
rubrifloralignan
isol
anoth
speci
schisandracea
familyschisandra
rubriflora
inhibit
format
syncytium
induc
cell
death
induc
also
inhibit
replic
hiv
mechanist
rubrifloralignan
shown
inhibit
earli
stage
replic
deriv
gomisin
exhibit
potent
antihiv
activ
ec
si
valu
respect
halogen
gomisin
j
deriv
shown
nonnucleosid
inhibitor
hiv
type
revers
transcriptas
neolignan
class
lignan
contain
also
refer
phenylpropan
linkag
characterist
classic
lignan
group
differ
subtyp
base
natur
posit
linkag
phenylpropan
unit
contrast
classic
lignan
report
antivir
activ
neolignan
figur
show
structur
neolignan
compound
lignan
subtyp
neolignan
receiv
signific
attent
year
due
good
biolog
activ
one
repres
silymarin
flavonolignan
isol
seed
silybum
marianum
commonli
consum
herbal
product
among
hcvinfect
patient
western
countri
besid
show
possess
antioxid
antiinflammatori
hepatoprotect
activ
recent
studi
also
document
antivir
activ
silymarin
deriv
hcv
virus
deriv
intraven
silibinin
name
legalon
sil
shown
block
hcv
product
increas
antiinflammatori
antiprolif
gene
express
without
affect
serum
albumin
level
clinic
phase
addit
show
silymarin
inhibit
replic
iav
moa
show
silymarin
inhibit
late
mrna
synthesi
iav
replic
also
report
silymarin
inhibit
virus
denv
chikungunya
viru
mayaro
viru
hiv
hbv
late
mrna
synthesi
iav
replic
also
report
silymarin
inhibit
virus
denv
chikungunya
viru
mayaro
viru
hiv
hbv
erythrostrebluslignanol
g
neolignan
also
dimer
strebluslignanol
isol
root
streblu
asper
exhibit
signific
antihbv
activ
secret
hbsag
hbeag
valu
respect
secolignan
cleavag
lignan
neolignan
presum
obtain
pyrolysi
oxid
cycliz
arylnaphthalen
report
compound
isol
plant
genu
peperomia
piperacea
urtica
urticacea
selaginella
selaginellacea
exhibit
antitumor
antiinflammatori
antihiv
insect
antifeed
pharmacolog
activ
two
compound
peperomin
b
isol
peperomia
pellucida
piperacea
show
moder
inhibitori
effect
iiib
growth
cell
valu
around
howev
appear
observ
bioactiv
due
cytotox
secolignan
cleavag
lignan
neolignan
presum
obtain
pyrolysi
oxid
cycliz
arylnaphthalen
report
compound
isol
plant
genu
peperomia
piperacea
urtica
urticacea
selaginella
selaginellacea
exhibit
antitumor
antiinflammatori
antihiv
insect
antifeed
pharmacolog
activ
two
compound
peperomin
b
isol
peperomia
pellucida
piperacea
show
moder
inhibitori
effect
iiib
growth
cell
ec
valu
around
howev
appear
observ
bioactiv
due
cytotox
compound
ic
inhibitori
concentr
compound
produc
inhibit
virusinduc
cytopath
effect
cc
concentr
reduc
growth
target
cell
lignan
tradit
defin
class
secondari
metabolit
deriv
oxid
dimer
two
phenylpropanoid
unit
boast
vast
structur
divers
despit
common
biosynthet
origin
also
wellestablish
class
compound
exhibit
rang
potent
biolog
activ
owe
factor
lignan
proven
challeng
desir
synthet
target
instig
develop
differ
synthet
method
advanc
collect
knowledg
toward
synthesi
complex
uniqu
structur
virusrel
diseas
becom
challeng
public
health
concern
increas
global
travel
emerg
viral
resist
clinic
antivir
drug
urgent
need
develop
novel
antivir
drug
target
differ
viral
host
protein
lignan
discuss
review
larg
structur
divers
pharmacolog
activ
includ
antivir
two
type
antivir
lignanspodophyllotoxin
bicyclol
show
high
potenc
treatment
vener
wart
chronic
hepat
b
respectivelyserv
good
exampl
develop
lignan
antivir
howev
believ
potenti
lignan
antivir
need
explor
research
develop
note
although
mani
classic
lignan
show
display
widerang
antivir
activ
littl
known
regard
neolignan
vari
structur
classic
lignan
regard
antivir
activ
neolignan
care
evalu
assess
activ
differ
virus
highli
like
mani
new
antivir
activ
discov
furthermor
action
mechan
studi
investig
facilit
develop
lead
lignan
antivir
drug
discoveri
